To Evaluate the Safety, Pharmacokinetics, and Efficacy of GB10 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)
Clinical trial NCT07406438 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07406438
- Sponsor
- Shenzhen Kexing Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-12
- Primary completion
- 2027-04-30
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.